(Q39228211)

10 September 2017

1 reference

title

When and how to use angiotensin-converting enzyme inhibition in congestive heart failure (English)

1 reference

10 September 2017

0 references

congestive heart failure

1 reference

Rydén L

1

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 July 1988

1 reference

American Journal of Cardiology

10 September 2017

published in

1 reference

10 September 2017

volume

62

1 reference

10 September 2017

issue

2

1 reference

10 September 2017

page(s)

75A-80A

1 reference

Concentration of renin in renal venous blood in patients with chronic heart failure

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Role of the renin-angiotensin system in the systemic vasoconstriction of chronic congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Angiotensin converting enzyme inhibition in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

The renin-angiotensin-aldosterone system in congestive failure in conscious dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Role of the renin-angiotensin system in the development of congestive heart failure in the dog as assessed by chronic converting-enzyme blockade.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Prevention of the development of heart failure and the regression of cardiac hypertrophy by captopril in the spontaneously hypertensive rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Increased survival in rats with congestive heart failure treated with enalapril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Activity of the sympathetic nervous system and renin-angiotensin system assessed by plasma hormone levels and their relation to hemodynamic abnormalities in congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Determinants of clinical response and survival in patients with congestive heart failure treated with captopril

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

A cooperative multicenter study of captopril in congestive heart failure: hemodynamic effects and long-term response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Hemodynamic and clinical response to enalapril, a long-acting converting-enzyme inhibitor, in patients with congestive heart failure.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Acute and long-term effects of enalapril on the cardiovascular response to exercise and exercise tolerance in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Captopril therapy for heart failure. A placebo controlled study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Captopril in heart failure. A double blind controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Usefulness of plasma renin activity in predicting haemodynamic and clinical responses and survival during long term converting enzyme inhibition in severe chronic heart failure. Experience in 100 consecutive patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Efficacy of captopril in low-renin congestive heart failure: importance of sustained reactive hyperreninemia in distinguishing responders from nonresponders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Severe hypotension after first dose of enalapril in heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Captopril therapy for severe CHF: hypotensive response in presence of markedly elevated PRA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Effect of captopril on renal function in patients with congestive heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Hemodynamic responses to combined therapy with captopril and hydralazine in patients with severe heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Variable clinical response to long-term angiotensin inhibition in severe heart failure: demonstration of additive benefits of alpha-receptor blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Comparative effects of captopril and isosorbide dinitrate on pulmonary arteriolar resistance and right ventricular function in patients with severe left ventricular failure: results of a randomized crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

Clinical importance of the renin-angiotensin system in chronic heart failure: double blind comparison of captopril and prazosin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2888%2980090-0

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9149(88)80090-0

1 reference

10 September 2017

1 reference